Skip to main content

Table 3 Hazard Ratios by Multivariable Analysis

From: Anesthetics and long-term survival after cancer surgery—total intravenous versus volatile anesthesia: a retrospective study

 

Cancer type included

Cancer type excluded

HR

95% Cl

P-value

HR

95% Cl

P-value

Sex: male vs female

1.031

0.625 to 1.700

0.905

1.731

1.078 to 2.781

0.023*

Weight, kg: >  57 vs ≤ 57

0.990

0.956 to 1.026

0.591

0.980

0.946 to 1.016

0.275

BMI, kg m−2: >  19.7 vs ≤ 19.7

0.983

0.889 to 1.087

0.743

1.015

0.917 to 1.122

0.777

Anesthesia time, min:

>  210 vs ≤ 210

1.001

0.998 to 1.003

0.573

1.000

0.998 to 1.002

0.911

Metastasis: no vs yes

0.119

0.078 to 0.180

< 0.001**

0.132

0.088 to 0.199

< 0.001**

Cancer type

 Breast (reference)

      

 Colon

2.594

0.917 to 7.341

0.072

   

 Liver

8.168

2.556 to 26.104

< 0.001**

   

 Lung

7.235

2.295 to 22.810

< 0.001**

   

 Stomach

6.576

2.533 to 17.069

< 0.001**

   
  1. Only variables with a significance level of P < 0.2 in univariable analysis were included in the multivariable model. BMI Body mass index, ASA American Society of Anesthesiologists, HR Hazard ratio, TIVA Total intravenous anesthesia, DM Diabetes mellitus; *P < 0.05; **P < 0.01
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us